Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
-304K
-
Total reported value, excl. options
-
$80M
-
Value change
-
-$1.6M
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$5.02
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2021
32 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q4 2021.
scPharmaceuticals Inc. - Common Stock (SCPH) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 53.4M outstanding shares and own 29.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.8M shares), 5AM Venture Management, LLC (3.83M shares), RA CAPITAL MANAGEMENT, L.P. (2.69M shares), AIGH Capital Management LLC (1.37M shares), Ikarian Capital, LLC (901K shares), VANGUARD GROUP INC (617K shares), J. Goldman & Co LP (370K shares), Worth Venture Partners, LLC (333K shares), RENAISSANCE TECHNOLOGIES LLC (189K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (132K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.